II. Epidemiology
- Relative Risk of Tobacco Abuse among teens using e-cigs: 4 fold increase
- Of teens, 80% have the misconception that Vaping is harmless
-
Prevalence (U.S.)
- High School: 1 in 9 (increased to 1 in 4 as of 2019)
- Middle School: 1 in 30
- Adults: 5%
III. Background
- In U.S., FDA will regulate e-cigs as Tobacco products as of August 2016
- In late 2021, Vuse was FDA approved
- However, this is not an FDA endorsement, only that the product may remain on market
IV. Mechanism
- Battery powered electronic device vaporizes a concentrated Nicotine liquid in a replaceable cartridge
- User inhales Nicotine vapor (or in some cases Marijuana or other substances)
- Various Nicotine preparations are sold and not regulated
- Some Nicotine solutions are flavored or colored (attracting young children)
-
Nicotine concentrations vary by device
- Juul 5% (high concentration)
- Blu 1.2%
- Labeling of Nicotine concentration is highly inaccurate
- Pods (e.g. Juul, Vuse) are alternative devices (appear similar to US drives)
V. Precautions
- Not recommended as Nicotine Replacement
- However in a COPD patient who refuses to quit Nicotine, e-cigs appear to cause less harm than Tobacco
- Cibella (2016) Clin Sci 130(21): 1929-37 [PubMed]
- Polosa (2016) Respir Res 17(1): 166 [PubMed]
- NOT a Nicotine Replacement device (unlike Nicotine Patch, Nicotine Gum)
- E-Cigarette may replace Tobacco, but subsequently weaning from E-Cig often fails (in contrast to Nicotine Replacement)
- Hajek (2019) N Engl J Med 380(7):629-37 [PubMed]
- Hartmann-Boyce (2021) Cochrane Database Syst Rev 4(4):CD010216 +PMID: 33913154 [PubMed]
- Vaping solutions contain various substances that may result in toxicity and foreign body reactions
- Typically Nicotine (Marijuana is also frequently used instead)
- Concentrated flavorings
- Propylene glycol
- Glycerol
- Other substances (e.g. nitrosamines, aldehydes, metals, volatile organics, polycyclic Aromatic Hydrocarbons)
- New, inventive way for companies (several that market Tobacco) to market an unregulated (in 2014), addictive Nicotine product
- E-Cigarette has had a recent increase in use among U.S. high school students
-
Nicotine solutions are not regulated and their labels may be inaccurate and their contents contaminated
- Inadequate safety data available for these devices and the inhaled vapor compared other Nicotine Replacement forms
VI. Adverse Effects: Nicotine Toxicity
- See Acute Nicotine Poisoning (esp. children)
- Nicotine solution is sold in large refillable 100 mg bottles
- Nicotine solutions are highly concentrated (up to 100 mg/ml)
- The solution is well absorbed by the Gastrointestinal Tract
- Toxicity risk is high when ingested by young children
- See Acute Nicotine Poisoning
- Toddlers experience symptoms with 1 mg ingestion
- Lethal dose at 6-13 mg/kg
-
Nicotine has a Succinylcholine-like stimulatory effect on Nicotinic Receptors
- Results in Seizures followed by paralysis
-
Nicotine affects teens differently than adults
- Teens are more likely to become addicted than adults
- Teens have a more significant adverse cognitive effect on memory and attention
- Teens are more likely to have respiratory adverse effects
- Longterm Vaping adverse cardiopulmonary effects are not yet clear
- May have carcinogenic effects
- Second hand exposure of potential toxins for friends and family
VII. Adverse Effects: Miscellaneous
- See Vaping-Associated Lung Disease
- See Acute Nicotine Poisoning
- Throat irritation
- Cough
- Nausea
- Disturbed sleep
-
Heavy Metal toxin and other contaminant exposure
- Lead
- Chromium
- Arsenic
- Propylene Glycol
- Formaldehyde
- Hydrogen cyanide has been isolated from black market cannibis Vaping solutions
- Nicotine is Teratogenic (effects fetal brain structure and function)
- E-Cigarette use increases increases risk of starting to use Cigarettes (Odds Ratio 3-6) and Marijuana
- E-Cigarette second-hand smoke exposure is common in middle and high school and triggers Asthma attacks
VIII. Prevention
- See E-Cigarette Cessation (same as Tobacco Cessation)
- Try to prevent teens from using e-cigs before they start
IX. Resources
X. References
- (2018) Presc Lett 25(11): 64
- (2014) Presc Lett 21(6): 36
- Swadron and Nordt in Herbert (2014) EM:Rap 14(6): 14
- Klein (2019) Am Fam Physician 100(4): 227-35 [PubMed]
- Vardavas (2012) Chest 141(6):1400-6 [PubMed]
- Trtchounian (2011) Tob Control 20:47-52 [PubMed]
- Berg (2022) Int J Environ Res Public Health 19(14):8518 +PMID: 35886373 [PubMed]